SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-19-007522
Filing Date
2019-02-14
Accepted
2019-02-14 06:10:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tv513725_sc13ga.htm SC 13G/A 46507
  Complete submission text file 0001144204-19-007522.txt   47932
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Bioblast Pharma Ltd. (Subject) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88278 | Film No.: 19600412
SIC: 2834 Pharmaceutical Preparations

Mailing Address ALCOBRA LTD., AMOT INVESTMENT BUILDING 2 WEIZMAN STREET, 9TH FLOOR TEL AVIV L3 6423902
Business Address
Gilboa Udi (Filed by) CIK: 0001599094 (see all company filings)

Type: SC 13G/A